vs
HARROW, INC.（HROW）与REGIS CORP（RGS）财务数据对比。点击上方公司名可切换其他公司
HARROW, INC.的季度营收约是REGIS CORP的1.6倍（$89.1M vs $57.1M），HARROW, INC.净利率更高（7.4% vs 0.8%，领先6.6%），HARROW, INC.同比增速更快（33.3% vs 22.3%），HARROW, INC.自由现金流更多（$8.1M vs $891.0K），过去两年HARROW, INC.的营收复合增速更高（60.5% vs 7.8%）
哈罗健康（前身为Imprimis制药）是一家上市制药企业，总部位于美国田纳西州纳什维尔，深耕制药领域相关业务，在医药研发、生产及商业化方面拥有成熟的运营体系，产品及服务覆盖多个医疗需求场景。
瑞吉斯公司是一家美国美发沙龙运营商，总部位于明尼苏达州明尼阿波利斯市。截至2021年8月，该集团旗下拥有5563家加盟沙龙以及276家直营门店，是北美地区规模领先的美发沙龙连锁经营企业。
HROW vs RGS — 直观对比
营收规模更大
HROW
是对方的1.6倍
$57.1M
营收增速更快
HROW
高出11.1%
22.3%
净利率更高
HROW
高出6.6%
0.8%
自由现金流更多
HROW
多$7.2M
$891.0K
两年增速更快
HROW
近两年复合增速
7.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $89.1M | $57.1M |
| 净利润 | $6.6M | $456.0K |
| 毛利率 | 79.3% | — |
| 营业利润率 | 17.5% | 10.8% |
| 净利率 | 7.4% | 0.8% |
| 营收同比 | 33.3% | 22.3% |
| 净利润同比 | -2.2% | -94.0% |
| 每股收益（稀释后） | $0.20 | $0.16 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收HROWRGS
| Q4 25 | $89.1M | $57.1M | ||
| Q3 25 | $71.6M | $59.0M | ||
| Q2 25 | $63.7M | $60.4M | ||
| Q1 25 | $47.8M | $57.0M | ||
| Q4 24 | $66.8M | $46.7M | ||
| Q3 24 | $49.3M | $46.1M | ||
| Q2 24 | $48.9M | $49.4M | ||
| Q1 24 | $34.6M | $49.2M |
净利润HROWRGS
| Q4 25 | $6.6M | $456.0K | ||
| Q3 25 | $1.0M | $1.4M | ||
| Q2 25 | $5.0M | $116.5M | ||
| Q1 25 | $-17.8M | $250.0K | ||
| Q4 24 | $6.8M | $7.6M | ||
| Q3 24 | $-4.2M | $-853.0K | ||
| Q2 24 | $-6.5M | $91.2M | ||
| Q1 24 | $-13.6M | $-2.3M |
毛利率HROWRGS
| Q4 25 | 79.3% | — | ||
| Q3 25 | 75.3% | — | ||
| Q2 25 | 74.5% | — | ||
| Q1 25 | 67.5% | — | ||
| Q4 24 | 78.8% | — | ||
| Q3 24 | 75.6% | — | ||
| Q2 24 | 74.4% | — | ||
| Q1 24 | 69.5% | — |
营业利润率HROWRGS
| Q4 25 | 17.5% | 10.8% | ||
| Q3 25 | 20.6% | 10.0% | ||
| Q2 25 | 17.9% | 12.1% | ||
| Q1 25 | -23.5% | 8.8% | ||
| Q4 24 | 19.3% | 11.8% | ||
| Q3 24 | 2.7% | 4.6% | ||
| Q2 24 | 3.1% | — | ||
| Q1 24 | -20.0% | 8.3% |
净利率HROWRGS
| Q4 25 | 7.4% | 0.8% | ||
| Q3 25 | 1.4% | 2.3% | ||
| Q2 25 | 7.8% | 192.9% | ||
| Q1 25 | -37.2% | 0.4% | ||
| Q4 24 | 10.1% | 16.4% | ||
| Q3 24 | -8.6% | -1.9% | ||
| Q2 24 | -13.2% | 184.7% | ||
| Q1 24 | -39.2% | -4.7% |
每股收益（稀释后）HROWRGS
| Q4 25 | $0.20 | $0.16 | ||
| Q3 25 | $0.03 | $0.49 | ||
| Q2 25 | $0.13 | $43.67 | ||
| Q1 25 | $-0.50 | $0.08 | ||
| Q4 24 | $0.19 | $2.71 | ||
| Q3 24 | $-0.12 | $-0.36 | ||
| Q2 24 | $-0.18 | $38.40 | ||
| Q1 24 | $-0.38 | $-1.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.9M | $18.4M |
| 总债务越低越好 | $250.0M | $113.3M |
| 股东权益账面价值 | $52.4M | $188.7M |
| 总资产 | $399.5M | $588.3M |
| 负债/权益比越低杠杆越低 | 4.77× | 0.60× |
8季度趋势，按日历期对齐
现金及短期投资HROWRGS
| Q4 25 | $72.9M | $18.4M | ||
| Q3 25 | $74.3M | $16.6M | ||
| Q2 25 | $53.0M | $17.0M | ||
| Q1 25 | $66.7M | $13.3M | ||
| Q4 24 | $47.2M | $10.2M | ||
| Q3 24 | $72.6M | $6.3M | ||
| Q2 24 | $71.0M | $10.1M | ||
| Q1 24 | $76.0M | $5.9M |
总债务HROWRGS
| Q4 25 | $250.0M | $113.3M | ||
| Q3 25 | $347.2M | $111.3M | ||
| Q2 25 | $250.6M | $110.8M | ||
| Q1 25 | $256.9M | $112.0M | ||
| Q4 24 | $262.7M | $111.5M | ||
| Q3 24 | $230.7M | $95.2M | ||
| Q2 24 | $236.3M | $99.5M | ||
| Q1 24 | $243.4M | $179.7M |
股东权益HROWRGS
| Q4 25 | $52.4M | $188.7M | ||
| Q3 25 | $47.0M | $187.6M | ||
| Q2 25 | $49.7M | $185.6M | ||
| Q1 25 | $56.5M | $68.6M | ||
| Q4 24 | $69.7M | $66.7M | ||
| Q3 24 | $58.0M | $56.4M | ||
| Q2 24 | $58.5M | $56.8M | ||
| Q1 24 | $60.6M | $-35.8M |
总资产HROWRGS
| Q4 25 | $399.5M | $588.3M | ||
| Q3 25 | $363.1M | $592.1M | ||
| Q2 25 | $345.0M | $599.0M | ||
| Q1 25 | $364.2M | $511.2M | ||
| Q4 24 | $389.0M | $530.1M | ||
| Q3 24 | $351.5M | $508.9M | ||
| Q2 24 | $306.6M | $530.5M | ||
| Q1 24 | $295.5M | $543.7M |
负债/权益比HROWRGS
| Q4 25 | 4.77× | 0.60× | ||
| Q3 25 | 7.39× | 0.59× | ||
| Q2 25 | 5.05× | 0.60× | ||
| Q1 25 | 4.55× | 1.63× | ||
| Q4 24 | 3.77× | 1.67× | ||
| Q3 24 | 3.98× | 1.69× | ||
| Q2 24 | 4.04× | 1.75× | ||
| Q1 24 | 4.02× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $8.4M | $1.7M |
| 自由现金流经营现金流 - 资本支出 | $8.1M | $891.0K |
| 自由现金流率自由现金流/营收 | 9.1% | 1.6% |
| 资本支出强度资本支出/营收 | 0.4% | 1.4% |
| 现金转化率经营现金流/净利润 | 1.27× | 3.65× |
| 过去12个月自由现金流最近4个季度 | $43.0M | $14.9M |
8季度趋势，按日历期对齐
经营现金流HROWRGS
| Q4 25 | $8.4M | $1.7M | ||
| Q3 25 | $16.6M | $2.3M | ||
| Q2 25 | $-803.0K | $6.8M | ||
| Q1 25 | $19.7M | $6.2M | ||
| Q4 24 | $-17.8M | $2.1M | ||
| Q3 24 | $3.0M | $-1.3M | ||
| Q2 24 | $-2.7M | $5.1M | ||
| Q1 24 | $-4.6M | $-277.0K |
自由现金流HROWRGS
| Q4 25 | $8.1M | $891.0K | ||
| Q3 25 | $16.4M | $1.9M | ||
| Q2 25 | $-969.0K | $6.2M | ||
| Q1 25 | $19.5M | $5.9M | ||
| Q4 24 | $-18.3M | $1.7M | ||
| Q3 24 | $2.3M | $-1.4M | ||
| Q2 24 | $-3.1M | $5.1M | ||
| Q1 24 | $-4.7M | $-326.0K |
自由现金流率HROWRGS
| Q4 25 | 9.1% | 1.6% | ||
| Q3 25 | 22.9% | 3.2% | ||
| Q2 25 | -1.5% | 10.3% | ||
| Q1 25 | 40.8% | 10.3% | ||
| Q4 24 | -27.4% | 3.6% | ||
| Q3 24 | 4.8% | -3.0% | ||
| Q2 24 | -6.3% | 10.3% | ||
| Q1 24 | -13.6% | -0.7% |
资本支出强度HROWRGS
| Q4 25 | 0.4% | 1.4% | ||
| Q3 25 | 0.3% | 0.7% | ||
| Q2 25 | 0.3% | 0.9% | ||
| Q1 25 | 0.4% | 0.6% | ||
| Q4 24 | 0.8% | 0.9% | ||
| Q3 24 | 1.2% | 0.0% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 0.3% | 0.1% |
现金转化率HROWRGS
| Q4 25 | 1.27× | 3.65× | ||
| Q3 25 | 16.26× | 1.68× | ||
| Q2 25 | -0.16× | 0.06× | ||
| Q1 25 | — | 24.80× | ||
| Q4 24 | -2.62× | 0.28× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 0.06× | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
HROW
暂无分部数据
RGS
| Franchise Segment | $37.9M | 66% |
| Royalty | $13.6M | 24% |
| Other | $2.8M | 5% |
| Fees | $1.8M | 3% |
| Franchise Fees | $1.0M | 2% |
